Demetrix, Inc. — Form D/A
Demetrix, Inc. of Berkeley, CA, a company, filed a Form D amendment with the SEC on 2021-02-10. The offering totals $50.5M, of which $50.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-02-10
- Form: D/A
- Accession: 0001716211-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.5M
- Amount sold: $50.0M
- Remaining: $500K
- Investors: 16
- Date of first sale: 2019-06-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-344040
Issuer
- Name: Demetrix, Inc.
- CIK: 0001716211
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 2929 7th Street, Suite 130, Berkeley, CA, 94710
- Phone: 510-990-0311
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| William Haseltine | Director | BERKELEY, CA |
| Jay Keasling | Director | Berkeley, CA |
| Marc Riiska | Director | New York City, NY |
| Jeffrey Ubersax | Director | BERKELEY, CA |
| Haorui Zhang | Director | BERKELEY, CA |
| Cynthia Bryant | Executive Officer | BERKELEY, CA |
| Darren Platt | Executive Officer | BERKELEY, CA |
| Jeffrey Ubersax | Executive Officer | BERKELEY, CA |
| Jay Keasling | Executive Officer | Berkeley, CA |
| William Haseltine | Executive Officer | BERKELEY, CA |
| Jeff Ubersax | Executive Officer | Emeryville, CA |
Other filings by this issuer (5)
More